Webcast
Prescient Therapeutics (ASX: PTX) Webcast Replay
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.
Pitt Street Research on Prescient Therapeutics
Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.
Far East Gold (ASX: FEG) Webcast Replay
In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……
VP Minerals (VPM) Webcast Replay
In this session VP Minerals (VPM) Non-Executive Director Graham Howard discussed VPM’s continued resource inventory targeting high grade critical mineral deposits.
Propell Holdings (ASX: PHL) Webcast Replay
In this session Propell CEO Michael Davidson discussed Propell’s recent progress on the platform, cost base, and establishing a broker network…
Prescient Therapeutics (ASX: PTX) Webcast Replay
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed the new PTX-100 Phase 1b clinical study results, following their unveiling at the American Society of Hematology (ASH) conference.
Wellnex Life (ASX: WNX) Webcast Replay
In this session Wellnex Life MD Zack Bozinovski, CEO George Karafotias and new Board appointment Andrew Vidler discussed how the transformative acquisition of leading topical pain relief brand Pain Away complements Wellnex Life’s position and growth strategy whilst adding immediate scale.
Far East Gold (ASX: FEG) Webcast Replay
In this session Far East Gold’s Chairman Paul Walker and GM of Exploration Mike Corey discussed the high-grade copper and gold mineralization identified through geological mapping and surface rock sampling at the Sentul and Buluroto prospect areas.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed Felix’s prospects in the world-class Alaskan region including high grade critical mineral antimony assays of up to 28% Sb.
Pitt Street Research on Prescient Therapeutics
Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.
Prescient Therapeutics (ASX: PTX) Webcast Replay
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update structured in a Q&A format to field key questions from investors. Steven discussed the key highlights.
Credit Clear Limited (ASX: CCR) Investor Briefing – 20 September
Credit Clear owns a communications platform that has attracted investments from some of Australia’s leading fund managers – from Alex Waislitz’s Thorney Investment Group, to Ellerston Capital. The company has grown its revenue at a 183% CAGR between FY18 and FY22 with the acquisition of two businesses and has experienced growth across all parts of the business. Credit Clear won ‘Best Use of AI’ at the 7th and 8th Annual Australian Fintech Awards and was also an ‘Insurtech Start-up of the Year’ finalist at the 2022 Australian and New Zealand Institute of Insurance and Finance awards. The company provides services to some of Australia’s largest companies, including TPG Telecom, Suncorp, Water Corporation and more.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.